精品国产一区二区桃色

Member News

Greer moves to V Foundation; Gentry named chair at UF

ASBMB Today Staff
July 25, 2022

Gentry to chair University of Florida BMB department

Matthew Gentry, until lately a professor of molecular and cellular biochemistry at the University of Kentucky College of Medicine, has been appointed chair of the biochemistry and molecular biology department at the University of Florida College of Medicine. He will start in late August.

Matthew Gentry

Gentry studies glycogen metabolism and how it goes awry in cancer and neurodegenerative disorders. Much of his early work focused on Lafora disease, a rare genetic disorder that causes progressive epilepsy beginning in adolescence. Lafora disease begins with the accumulation of insoluble polysaccharides in neurons and astrocytes. In collaboration with multiple groups and companies, Gentry’s laboratory has developed several potential therapeutic approaches for Lafora disease.  He has worked with patients and their families to organize scientific meetings sponsored by a patient advocacy group called Chelsea's Hope.

Gentry earned his Ph.D. at Syracuse University and was a postdoc at the University of California San Diego with Jack Dixon before joining the University of Kentucky faculty. He is a member of the 精品国产一区二区桃色 Council, former chair of the 精品国产一区二区桃色 public affairs advisory committee and a member of the Journal of Biological Chemistry editorial board.

Greer joins V Foundation

Susanna Greer, until recently a senior scientific director at the American Cancer Society, has assumed a new position as the chief scientific officer at the V Foundation for Cancer Research, a North Carolina–based nonprofit. She will work with the foundation's scientific advisory committee to set funding priorities.

Susanna Greer

Greer earned her Ph.D. in microbiology and immunology at the University of Alabama at Birmingham, and was a postdoc at the University of North Carolina Chapel Hill. She spent just over 10 years as a professor studying cancer epigenetics at Georgia State University, earning tenure before she started a scientific communication consultancy and transitioned into the nonprofit world.

Greer serves on the Council and the Finance Committee of 精品国产一区二区桃色 and was named an ASBMB fellow earlier this year. She also has served on several National Cancer Institute committees and was previously chair of the ASBMB committee on outreach and science communication.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.